Skip to content
China Healthcare Group
Home Email us Contact Us
Home
China's Pharmaceutical Market is Worth around USD12 Billion According to New Report
China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around USD12 billion.
China's Pharmaceutical Market is Worth around USD12 Billion According to New Report PDF Print E-mail
Written by BUSINESS WIRE   
Jul 12, 2007 at 09:30 AM
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c62400) has announced the addition of The China Pharmaceutical Market: A Strategic Opportunity Analysis to their offering.

China has become an attractive destination for R&D as new opportunities have emerged following its WTO (World Trade Organization) accession. Development has accelerated both industrially and scientifically, and today the Chinese pharmaceutical market is worth around USD12 billion.

Factors fuelling the developmental growth and attracting foreign investors to the area include low labor costs, high quality clinical data and an abundance of R&D collaborative opportunities and facilities.

Global biotechnology within China has also undergone significant growth, promising enormous potential for new companies. Biotechnology companies in the country have already grown quicker than pharmaceutical companies.

The report discusses the whole of the Chinese pharmaceutical market, taking readers through the history and current state of the healthcare system through to the regulations governing the country and its growing R&D capabilities. Detailing the driving forces behind the pharma market and including a full breakdown of the biopharma opportunities, including the contacts of active Chinese companies, the report is an essential resource to understand and access this lucrative market.

Reasons to purchase this report:

- Identify key partners

- Assess the current market opportunity

- Learn how newly implemented government changes have altered the face of the industry

- Understand the organization and success of clinical trials in China

- Create strategies for profitable market access into China

The Chinese government also plays an instrumental role in the pharmaceutical development of China. The introduction of WTO guidelines and protection for intellectual property rights has caused a shift in the company structures of China, forcing some to close business or enter into new collaborations.

Ideally suited for individuals wishing to introduce their companies into this emerging market or review the opportunities available, this report provides a perfect resource to identify the current pattern of the market and understand the regulations that operate within the country.

 
< Prev   Next >

Service Activities

Login to Access Our Archive


  Lost Password?       Register